Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Research Applications and Considerations GHK-Cu liver research covers HSC activation inhibition via JNK/AP-1 and Nrf2/MMP-13 pathways, TGF-1 Smad-independent signalling modulation, primary hepatocyte oxidative cytoprotection (HO, APAP, ethanol models), CCl in vivo fibrosis attenuation with Sirius Red and hydroxyproline endpoints, NAFLD/MASLD lipid accumulation via AMPK-CPT1A-FAO, metallothionein copper buffering and ICP-MS hepatic copper quantitation, and alcohol-induced steatohepatitis antioxidant protection
Oral, BBB-penetrant delivery: The medicinal-chemistry program characterized Dihexa as metabolically stable and orally active enough to reach the brain in animals the property that distinguished it from earlier AngIV peptides [1]
Most cycles run 4 to 12 weeks depending on the goal
This includes syringes, needles, alcohol swabs, and a sharps disposal container
Typical Treatment Timeline During weeks one through two, most patients notice minimal external changes
Read together with the failed fosgonimeton trial, the takeaway is that the human-relevant evidence base for this class is both thin and, where it touched humans, negative
US$ 24.86
US$ 25.07
US$ 20.83
US$ 25.26
US$ 28.30
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
